Loading...
Loading...
According to Piper Jaffray, Thoratec
THOR price target is raised to $33.
Piper Jaffray said that it is incrementally more positive on Neutral-rated THOR after attending the HFSA convention in Boston. “We are increasing our price target to $33/share to reflect current Medtech multiples and our updated estimates.”
Thoratec closed yesterday at $30.43.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in